Atlas Trials

Zurig (Febuxostat) 40mg Efficacy and Safety Trial

Clinical trial NCT02600780 · COMPLETED

Trial details

NCT number
NCT02600780
Sponsor
Getz Pharma
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hyperuricemia
Start date
2013-11-01
Primary completion
2014-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.